Medazolam

# Medazolam ## Overview - **Classification**: Benzodiazepine, short-acting - **Mechanism**: Enhances the effect of gamma-aminobutyric acid (GABA) at GABA-A receptors, leading to central nervous system (CNS) depression, sedation, anxiolysis, amnesia, and anticonvulsant effects. ## Primary Indications 1. **Preprocedural Sedation**: Provides sedation, anxiolysis, and anterograde amnesia prior to diagnostic or therapeutic procedures. 2. **Induction & Maintenance of Anesthesia**: Used for induction of general anesthesia and as a component of balanced anesthesia. 3. **Acute Seizures/Status Epilepticus**: Management of acute, prolonged convulsive seizures. 4. **Continuous Sedation**: For mechanically ventilated patients in critical care settings. ## Adult Dosing ### Standard Dosing **Preprocedural Sedation (IV)** - **Dose**: **0.02-0.1 mg/kg** - **Frequency**: Administer slowly over 2-3 minutes; wait 2 minutes to assess effect. - **Route**: Intravenous (IV) - **Maximum**: Single dose **2.5-5 mg**; total dose **5 mg**. **Induction of Anesthesia (IV)** - **Dose**: **0.1-0.35 mg/kg** - **Frequency**: Administer slowly over 20-30 seconds. - **Route**: Intravenous (IV) - **Maximum**: **6 mg** total. **Acute Seizures/Status Epilepticus (Off-label for IM/IN/Buccal in adults but common)** - **Dose**: **5-10 mg** - **Frequency**: Single dose; may repeat once after 10-15 min if needed. - **Route**: Intramuscular (IM), Intranasal (IN), or Buccal. **Continuous Sedation (ICU) (IV Infusion)** - **Loading Dose**: **0.01-0.05 mg/kg** IV over several minutes. - **Maintenance Infusion**: **0.02-0.1 mg/kg/hour** (**1-7 mg/hr** for most adults). - **Frequency**: Continuous infusion. - **Maximum**: Infusion rates up to **0.2 mg/kg/hour** for refractory cases. ### Dose Adjustments - **Renal Impairment (CrCl <30 mL/min)**: Consider **50% dose reduction** for bolus doses. Monitor closely for prolonged sedation due to active metabolite accumulation. - **Hepatic Impairment (Child-Pugh B/C)**: Reduce dose by **30-50%**. Titrate slowly due to impaired metabolism and prolonged effects. - **Elderly Patients (>60 years)**: Reduce dose by **at least 30-50%**. Start at the lower end of the dosing range (e.g., **0.01-0.03 mg/kg** for sedation) and titrate slowly due to increased sensitivity and prolonged half-life. ## Pediatric Dosing ### Neonates (0-28 days) - **Indication**: Sedation, anxiolysis for procedures or mechanical ventilation. - **Dose (IV Loading)**: **0.03-0.05 mg/kg** over 5 minutes. - **Dose (IV Maintenance)**: **0.01-0.06 mg/kg/hour** (10-60 mcg/kg/hour). - **Maximum**: **0.06 mg/kg/hour**. - **Special Notes**: Longer elimination half-life; high risk of respiratory depression. Avoid formulations with benzyl alcohol if possible. ### Infants (1-12 months) - **Indication**: Preprocedural sedation, acute seizures. - **Dose (IV Sedation)**: **0.05-0.1 mg/kg** IV over 2-3 minutes. - **Dose (IM Sedation)**: **0.05-0.15 mg/kg** IM. - **Dose (Buccal/IN for seizures)**: **0.2-0.3 mg/kg** (off-label). - **Maximum**: Single IV dose **6 mg**; single IM dose **6 mg**; single Buccal/IN dose **10 mg**. ### Children (1-12 years) - **Indication**: Preprocedural sedation, acute seizures. - **Dose (Oral Sedation)**: **0.25-0.5 mg/kg** PO, 30-45 min prior. - **Dose (IV Sedation)**: **0.05-0.1 mg/kg** IV over 2-3 minutes. - **Dose (IM Sedation)**: **0.05-0.15 mg/kg** IM. - **Dose (Buccal/IN for seizures)**: **0.2-0.3 mg/kg** (off-label). - **Maximum**: Total oral dose **20 mg**; single IV/IM dose **6 mg**; single Buccal/IN dose **10 mg**. ### Adolescents (13-18 years) - **Indication**: Preprocedural sedation, acute seizures, anesthesia. - **Dose**: Approach adult dosing, starting at the lower end and titrating slowly. - **Maximum**: Adult dose limits apply. ## Safety Information ### Contraindications - **Absolute**: Acute narrow-angle glaucoma. - **Absolute**: Hypersensitivity to benzodiazepines. - **Absolute**: Concomitant use with potent CYP3A4 inhibitors (e.g., itraconazole, ketoconazole) due to risk of profound sedation. - **Absolute**: Intrathecal or epidural administration (due to benzyl alcohol toxicity in some formulations). ### Common Adverse Effects - **Very Common (>10%)**: Sedation, respiratory depression, apnea, hypotension. - **Common (1-10%)**: Drowsiness, headache, nausea, vomiting, injection site reactions. - **Serious but Rare**: Paradoxical reactions (agitation, combativeness), cardiac arrest, seizures (upon rapid withdrawal). ### Key Drug Interactions - **Opioids/Other CNS Depressants (e.g., alcohol, barbiturates)**: Profound sedation, respiratory depression, coma, death. **Avoid concomitant use or significantly reduce doses of both, monitor closely.** - **Strong CYP3A4 Inhibitors (e.g., itraconazole, ketoconazole, clarithromycin, protease inhibitors, grapefruit juice)**: Markedly increased midazolam levels, prolonged sedation. **Contraindicated for IV use; avoid or significantly reduce dose for other routes.** - **CYP3A4 Inducers (e.g., rifampin, carbamazepine, phenytoin, St. John's Wort)**: Decreased midazolam levels, reduced efficacy. May require increased midazolam dose. ## Monitoring & Follow-up - **Before Treatment**: Baseline vital signs (HR, BP, RR, SpO2), level of consciousness (LOC). - **During Treatment**: Continuous monitoring of vital signs, respiratory status (SpO2, capnography if available), LOC, airway patency, and cardiac function. - **Clinical Signs**: Watch for respiratory depression, apnea, hypoxemia, hypotension, bradycardia, and oversedation. ## Clinical Pearls - 💡 **Tip 1**: Always titrate slowly to effect, especially in elderly, debilitated, or pediatric patients, to minimize the risk of respiratory depression and hypotension. - 💡 **Tip 2**: Have resuscitation equipment (e.g., bag-valve mask, intubation supplies) and flumazenil (benzodiazepine antagonist) immediately available when administering IV midazolam. - 💡 **Tip 3**: Midazolam has a rapid onset and short duration of action, making it suitable for brief procedures. However, active metabolites can prolong effects, especially with impaired renal or hepatic function. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.